390 related articles for article (PubMed ID: 18258752)
1. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.
de la Iglesia N; Konopka G; Puram SV; Chan JA; Bachoo RM; You MJ; Levy DE; Depinho RA; Bonni A
Genes Dev; 2008 Feb; 22(4):449-62. PubMed ID: 18258752
[TBL] [Abstract][Full Text] [Related]
2. STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation.
Puram SV; Yeung CM; Jahani-Asl A; Lin C; de la Iglesia N; Konopka G; Jackson-Grusby L; Bonni A
J Neurosci; 2012 Jun; 32(23):7806-18. PubMed ID: 22674257
[TBL] [Abstract][Full Text] [Related]
3. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.
Lal B; Goodwin CR; Sang Y; Foss CA; Cornet K; Muzamil S; Pomper MG; Kim J; Laterra J
Mol Cancer Ther; 2009 Jul; 8(7):1751-60. PubMed ID: 19584231
[TBL] [Abstract][Full Text] [Related]
4. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.
de la Iglesia N; Konopka G; Lim KL; Nutt CL; Bromberg JF; Frank DA; Mischel PS; Louis DN; Bonni A
J Neurosci; 2008 Jun; 28(23):5870-8. PubMed ID: 18524891
[TBL] [Abstract][Full Text] [Related]
6. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line.
Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS
Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408
[TBL] [Abstract][Full Text] [Related]
7. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
[TBL] [Abstract][Full Text] [Related]
8. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
Fan QW; Cheng CK; Gustafson WC; Charron E; Zipper P; Wong RA; Chen J; Lau J; Knobbe-Thomsen C; Weller M; Jura N; Reifenberger G; Shokat KM; Weiss WA
Cancer Cell; 2013 Oct; 24(4):438-49. PubMed ID: 24135280
[TBL] [Abstract][Full Text] [Related]
9. Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.
Vitucci M; Karpinich NO; Bash RE; Werneke AM; Schmid RS; White KK; McNeill RS; Huff B; Wang S; Van Dyke T; Miller CR
Neuro Oncol; 2013 Oct; 15(10):1317-29. PubMed ID: 23814263
[TBL] [Abstract][Full Text] [Related]
10. STAT3 regulation of glioblastoma pathogenesis.
de la Iglesia N; Puram SV; Bonni A
Curr Mol Med; 2009 Jun; 9(5):580-90. PubMed ID: 19601808
[TBL] [Abstract][Full Text] [Related]
11. Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.
Jahani-Asl A; Yin H; Soleimani VD; Haque T; Luchman HA; Chang NC; Sincennes MC; Puram SV; Scott AM; Lorimer IA; Perkins TJ; Ligon KL; Weiss S; Rudnicki MA; Bonni A
Nat Neurosci; 2016 Jun; 19(6):798-806. PubMed ID: 27110918
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
Garnett J; Chumbalkar V; Vaillant B; Gururaj AE; Hill KS; Latha K; Yao J; Priebe W; Colman H; Elferink LA; Bogler O
Neoplasia; 2013 Jan; 15(1):73-84. PubMed ID: 23359207
[TBL] [Abstract][Full Text] [Related]
13. Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.
Mehrian-Shai R; Chen CD; Shi T; Horvath S; Nelson SF; Reichardt JK; Sawyers CL
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5563-8. PubMed ID: 17372210
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes.
Lo HW; Cao X; Zhu H; Ali-Osman F
Mol Cancer Res; 2010 Feb; 8(2):232-45. PubMed ID: 20145033
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma.
Wang Y; Wong CW; Yan M; Li L; Liu T; Or PM; Tsui SK; Waye MM; Chan AM
Cancer Lett; 2018 Aug; 429():54-65. PubMed ID: 29729901
[TBL] [Abstract][Full Text] [Related]
16. Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells.
Wu J; Feng X; Zhang B; Li J; Xu X; Liu J; Wang X; Wang J; Tong X
J Neurooncol; 2014 Oct; 120(1):33-41. PubMed ID: 25048528
[TBL] [Abstract][Full Text] [Related]
17. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
[TBL] [Abstract][Full Text] [Related]
18. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
[TBL] [Abstract][Full Text] [Related]
19. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.
Li L; Dutra A; Pak E; Labrie JE; Gerstein RM; Pandolfi PP; Recht LD; Ross AH
Neuro Oncol; 2009 Feb; 11(1):9-21. PubMed ID: 18812521
[TBL] [Abstract][Full Text] [Related]
20. EGFR and EGFRvIII in glioblastoma: partners in crime.
Zadeh G; Bhat KP; Aldape K
Cancer Cell; 2013 Oct; 24(4):403-4. PubMed ID: 24135276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
